DIN 02527189 — APO-DAPAGLIFLOZIN 5 MG
APO-DAPAGLIFLOZIN is a tablet of Dapagliflozin marketed by APOTEX INC. The full Dapagliflozin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02527189
- Brand name
- APO-DAPAGLIFLOZIN
- Active ingredient
- Dapagliflozin
- Strength
- 5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- APOTEX INC
- Health Canada status
- MARKETED
- Drug class
- Sodium-glucose co-transporter 2 (SGLT2) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Dapagliflozin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02543192 | ACCEL-DAPAGLIFLOZIN | 10 MG | TABLET | ACCEL PHARMA INC | MARKETED |
| 02543184 | ACCEL-DAPAGLIFLOZIN | 5 MG | TABLET | ACCEL PHARMA INC | MARKETED |
| 02533057 | AG-DAPAGLIFLOZIN | 10 MG | TABLET | ANGITA PHARMA INC. | MARKETED |
| 02533049 | AG-DAPAGLIFLOZIN | 5 MG | TABLET | ANGITA PHARMA INC. | MARKETED |
| 02527197 | APO-DAPAGLIFLOZIN | 10 MG | TABLET | APOTEX INC | MARKETED |
| 02531410 | AURO-DAPAGLIFLOZIN | 10 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02531402 | AURO-DAPAGLIFLOZIN | 5 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02561336 | DAPAGLIFLOZIN | 10 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02561328 | DAPAGLIFLOZIN | 5 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02435470 | FORXIGA | 10 MG | TABLET | ASTRAZENECA CANADA INC | MARKETED |
| 02435462 | FORXIGA | 5 MG | TABLET | ASTRAZENECA CANADA INC | MARKETED |
| 02519860 | GLN-DAPAGLIFLOZIN | 10 MG | TABLET | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED |
| 02519852 | GLN-DAPAGLIFLOZIN | 5 MG | TABLET | GLENMARK PHARMACEUTICALS CANADA INC. | MARKETED |
| 02531372 | JAMP DAPAGLIFLOZIN | 10 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02531364 | JAMP DAPAGLIFLOZIN | 5 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02535300 | M-DAPAGLIFLOZIN | 10 MG | TABLET | MANTRA PHARMA INC | MARKETED |
| 02535297 | M-DAPAGLIFLOZIN | 5 MG | TABLET | MANTRA PHARMA INC | MARKETED |
| 02538342 | NRA-DAPAGLIFLOZIN | 10 MG | TABLET | NORA PHARMA INC | MARKETED |
| 02538334 | NRA-DAPAGLIFLOZIN | 5 MG | TABLET | NORA PHARMA INC | MARKETED |
| 02531569 | PMS-DAPAGLIFLOZIN | 10 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02531550 | PMS-DAPAGLIFLOZIN | 5 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02537664 | PRO-DAPAGLIFLOZIN | 10 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02537656 | PRO-DAPAGLIFLOZIN | 5 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02528983 | RIVA-DAPAGLIFLOZIN | 10 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED |
| 02528975 | RIVA-DAPAGLIFLOZIN | 5 MG | TABLET | LABORATOIRE RIVA INC. | MARKETED |
| 02518740 | SANDOZ DAPAGLIFLOZIN | 10 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02518732 | SANDOZ DAPAGLIFLOZIN | 5 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |